Dabigatran vs Pembrolizumab

## Dabigatran vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Dabigatran** and **Pembrolizumab**.

## Mechanism of Action

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Dabigatran — 12-17 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Dabigatran — C25H25N7O3; Pembrolizumab — N/A.

**Molecular Weight**: Dabigatran — 471.5100 g/mol; Pembrolizumab — N/A.

**Type**: Dabigatran — Small molecule; Pembrolizumab — Antibody.